Gonapeptyl Cr Ampoule 3.75Mg contains long-acting triptorelin 3.75 mg, a gonadotropin-releasing hormone analogue used under specialist supervision for hormone-dependent advanced prostate cancer, endometriosis, symptomatic uterine fibroids and confirmed central precocious puberty.

Ingredients: Each prolonged-release pre-filled syringe contains triptorelin 3.75 mg as triptorelin acetate, with a supplied solvent for reconstitution.

How to use: A trained healthcare professional reconstitutes and administers the prolonged-release suspension by deep intramuscular or subcutaneous injection according to the approved indication, generally every 28 days. Treatment and monitoring must remain under the relevant specialist.

Important safety information: Hot flushes, sweating, headache, mood or sleep changes, reduced libido, injection-site reactions, pelvic or bone pain and vaginal bleeding may occur. Severe depression, sudden severe headache with visual symptoms, allergic swelling, breathing difficulty or initial worsening of prostate-cancer symptoms requires urgent assessment. Bone density may decrease with prolonged treatment.

This information supports safe use and does not replace individual advice from a qualified healthcare professional.